Skip to main content
. 2011 Jul 12;52(11):2117–2123. doi: 10.3109/10428194.2011.592623

Table III.

Six-month mean cost per patient per month overall and by category.

Service No progression (n = 734) Progression (n = 268) Cp–CNP Cp/CNP p-Value*
Overall cost 859.98 3527.4 2667.4 4.10 <0.001
 Outpatient visits 36.68 99.92 63.24 2.72 <0.001
 Acute care 2.46 24.14 21.68 9.81 <0.001
 Chemotherapy 655.75 2495.01 1839.26 3.8 <0.001
  R-mono 487.07 849.50 362.43 1.74 <0.001
  R-chemo 166.07 1610.86 1444.79 9.69 <0.001
  Chemo 2.61 34.65 32.04 13.27 <0.001
 Other medication 101.86 700.28 598.42 6.87 <0.001
 Laboratories 11.35 28.53 17.18 2.51 <0.001
 Minor procedures 2.79 8.79 6.00 3.15 <0.001
 Other 0.59 3.02 2.43 5.11 <0.001
 XRT 15.07 71.27 38.93 4.72 <0.001
 RAD non-XRT 32.59 95.41 62.82 2.92 <0.001

Cp, cost of progression; CNp, cost of not progressing; R-mono, rituximab monotherapy; R-chemo, rituximab-chemotherapy; Chemo, chemotherapy only; XRT, external radiation treatment; RAD non-XRT, radiation other than XRT.

*

Mann-Whitney U-test.

lnpatient and ER visits.